Clinical Trials Directory

Trials / Unknown

UnknownNCT04358198

AI in GIM Diagnosis

Usefulness of Artificial Intelligence (AI) for Gastric Intestinal Metaplasia Diagnosis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
King Chulalongkorn Memorial Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will use artificial intelligence (AI) for diagnosing gastric intestinal metaplasia.

Detailed description

The patients with previously diagnose gastric intestinal metaplasia (GIM) and have the surveillance gastroscopy will be enrolled. The routine surveillance program will be performed additional to taking photo at both GIM and normal mucosa at least 5 pictures in each. Biopsy will be done to confirm the diagnosis of GIM and normal mucosa. All pictures will be inserted to AI algorithm based on the convolutional neural network (CNN). Then, the AI program will be validated in daily endoscopy compared with pathology. Accuracy, sensitivity and specificity can be calculated by 2x2 table.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTArtificial intelligenceThe AI algorithm based on the convolutional neural network (CNN) will be used for analysis the pictures of gastric intestinal metaplasia and normal mucosa. Then AI will be used as a diagnostic tool for GIM during routine endoscopy by using pathology as a gold standard.

Timeline

Start date
2020-05-01
Primary completion
2023-11-30
Completion
2024-02-28
First posted
2020-04-24
Last updated
2022-03-31

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT04358198. Inclusion in this directory is not an endorsement.